ES8801536A1 - Procedimiento de obtencion de un injerto para la administracion parental de un derivado de feniletanolamina. - Google Patents

Procedimiento de obtencion de un injerto para la administracion parental de un derivado de feniletanolamina.

Info

Publication number
ES8801536A1
ES8801536A1 ES556763A ES556763A ES8801536A1 ES 8801536 A1 ES8801536 A1 ES 8801536A1 ES 556763 A ES556763 A ES 556763A ES 556763 A ES556763 A ES 556763A ES 8801536 A1 ES8801536 A1 ES 8801536A1
Authority
ES
Spain
Prior art keywords
graft
coating
procedure
obtaining
parental administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556763A
Other languages
English (en)
Other versions
ES556763A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES8801536A1 publication Critical patent/ES8801536A1/es
Publication of ES556763A0 publication Critical patent/ES556763A0/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Materials For Medical Uses (AREA)
  • Table Devices Or Equipment (AREA)
  • Stringed Musical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

METODO DE PRODUCCION DE INJERTOS PARA ADMINISTRACION PARENTAL DE PEPTIDOS. CONSISTE EN COMPACTAR, EN FORMA DE INJERTO, UNA SAL DE ACIDO GRASO DE 10 A 20 ATOMOS DE CARBONO DEL P''PETIDO HIS-D-TRP-ALA-TRP-D-PHE-LYS-NH2, SOLUBLE EN MEDIO FISIOLOGICO ACUOSO; REVESTIR EL INJERTO CON UN MATERIAL BIODEGRADABLE; CURAR EL REVESTIMIENTO A 40JC DURANTE 5 HORAS; Y SEPARAR UNA SECCION DEL REVESTIMIENTO PARA DEJAR EXPUESTO EL PEPTIDO. TIENE APLICACIONES PARA LA PREPARACION DE FORMULACIONES FARMACOLOGICAS DE LIBERACION CONTINUADA.
ES556763A 1985-07-29 1986-06-25 Procedimiento de obtencion de un injerto para la administracion parental de un derivado de feniletanolamina. Expired ES8801536A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75970285A 1985-07-29 1985-07-29

Publications (2)

Publication Number Publication Date
ES8801536A1 true ES8801536A1 (es) 1988-02-16
ES556763A0 ES556763A0 (es) 1988-02-16

Family

ID=25056644

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556763A Expired ES8801536A1 (es) 1985-07-29 1986-06-25 Procedimiento de obtencion de un injerto para la administracion parental de un derivado de feniletanolamina.

Country Status (15)

Country Link
EP (1) EP0211266B1 (es)
JP (1) JPS6229518A (es)
KR (1) KR870000926A (es)
AT (1) ATE58829T1 (es)
AU (2) AU6062286A (es)
CA (1) CA1286608C (es)
DE (1) DE3675995D1 (es)
DK (1) DK350186A (es)
ES (1) ES8801536A1 (es)
FI (1) FI85944C (es)
GR (1) GR861983B (es)
IL (1) IL79133A0 (es)
NO (1) NO170457C (es)
NZ (1) NZ216881A (es)
ZA (1) ZA865632B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2619312B1 (fr) * 1987-08-13 1990-05-11 Roussel Uclaf Nouvelles compositions zootechniques renfermant un beta adrenergique et un steroide
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
US5045353A (en) * 1988-09-28 1991-09-03 Hitachi, Ltd. Method for treating interior surfaces of holes and apparatus therefor
KR950007873A (ko) * 1993-09-20 1995-04-15 후꾸하라 요시하루 생리 활성 물질 지속 방출형의 의약 제제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517513A (en) * 1943-02-27 1950-08-01 Vaernet Carl Pharmaceutical preparation for implantation
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
US4404222A (en) * 1980-08-25 1983-09-13 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby
EP0049728B1 (en) * 1980-08-25 1986-11-12 American Cyanamid Company Method for enhancing the growth rate of meat-producing animals and for improving the lean meat to fat ratio thereof
US4404224A (en) * 1981-12-02 1983-09-13 American Cyanamid Company Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm blooded animals
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
US4552897A (en) * 1983-02-01 1985-11-12 American Cyanamid Company Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom

Also Published As

Publication number Publication date
NO863026D0 (no) 1986-07-28
NO170457C (no) 1992-10-21
FI863079A7 (fi) 1987-01-30
FI85944C (fi) 1992-06-25
AU5605890A (en) 1990-09-20
NZ216881A (en) 1990-05-28
KR870000926A (ko) 1987-03-10
IL79133A0 (en) 1986-09-30
ATE58829T1 (de) 1990-12-15
NO863026L (no) 1987-01-30
ZA865632B (en) 1987-03-25
NO170457B (no) 1992-07-13
AU626420B2 (en) 1992-07-30
FI863079A0 (fi) 1986-07-28
GR861983B (en) 1986-12-29
AU6062286A (en) 1987-02-05
CA1286608C (en) 1991-07-23
FI85944B (fi) 1992-03-13
JPS6229518A (ja) 1987-02-07
DK350186D0 (da) 1986-07-23
DE3675995D1 (de) 1991-01-17
DK350186A (da) 1987-01-30
EP0211266B1 (en) 1990-12-05
ES556763A0 (es) 1988-02-16
EP0211266A2 (en) 1987-02-25
EP0211266A3 (en) 1987-10-07

Similar Documents

Publication Publication Date Title
ES8705886A1 (es) Un metodo para preparar un derivadode tiazolidin-diona
ES2169762T3 (es) Liberacion continua de peptidos a partir de composiciones farmaceuticas.
ES2067231T3 (es) Formas de dosificado para suministrar un agente antiparkinson.
NL191332C (nl) Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur.
HUT69178A (en) Process for producing peptides of growth hormone releasing activity
ES2010561A6 (es) Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina.
CS708386A2 (en) Method of pharmaceutical production
DE3588095D1 (de) Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung
ATE214284T1 (de) Verfahren zur herstellung aktiver substanzen aus perlmutt, resultierende produkte, geeignet für medizinische anwendungen
ES8801536A1 (es) Procedimiento de obtencion de un injerto para la administracion parental de un derivado de feniletanolamina.
ES8203376A1 (es) Procedimiento para obtener acidos 6-cloro- o 6-bromo-1,2-di-hidro-3h-pirrolo(1,2-a)pirrol-1-carboxilicos y sus derivados
PT80837A (de) Kombinationspraeparat aus pyrimido-pyrimidinen und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
IT1222412B (it) Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
FR2537130B1 (fr) Derives d'acides b-hydroxybutyriques, leur procede de preparation et leur application a la preparation de l-carnitine
NZ223343A (en) Dry formulations for the preparation of aqueous stable suspension for the parental administration of o-(2,6-dichloroanilino)phenylacetic acid (diclofenac)
GR3004863T3 (es)
DE69911224D1 (de) Geschmacksmaskierte kautablette mit sofortiger wirkstofffreisetzung sowie herstellungsverfahren
IL65443A (en) Calcium salts of beta-(4,5-diphenyl-oxazol-2-yl)-propionic acid and pharmaceutical compositions containing them
MX9302711A (es) Preparacion de base.
AT329035B (de) Verfahren zur herstellung neuer 1-(p-(2'- acylaminovinyl) -phenoxy) -2-hydroxy-3- aminopropane und ihrer saureadditionssalze
SE8705035L (sv) Anvaendning av alkylglycerol
ATE118348T1 (de) Liposome hoher stabilität und verfahren zur herstellung und verwendung.
Mignon et al. Ultrastructure of the Gingival Epithelium in the New Born Cat—Some Characteristics of the Intercellular Junctions
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
JPS57106644A (en) Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001